CompaniesOncodesign

Oncodesign

defunct

About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (2)

Total Trials

2

As Lead Sponsor

1

As Collaborator

1

Total Enrollment

628

By Phase

PHASE1: 1NA: 1

By Status

COMPLETED: 1UNKNOWN: 1

Clinical Trials Pipeline2 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2017

2018

2019

2020

2021

2022

2023

2024

Today

Hover over trial bars to see details

Recent Trials

NCT05025072Collaborator

A Bioequivalence Study to Compare the Pharmacokinetics of Two Formulations of Siklos® in Healthy Volunteers

PHASE1Completed

28 participants

Started: Aug 22, 2021 · Completed: Sep 29, 2021

NCT04548960Lead Sponsor

OncoSNIPE - Study of Molecular Profiles Associated With the Development of Resistance in Solid Cancer Patients

600 participants

Started: Jan 6, 2018 · Completed: Mar 31, 2023